Lynch RC, Cassaday RD, Smith SD, Cowan AJ, et al. Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma. Br J Haematol 2025;207:1599-1603.
PMID: 41070684